Agriculture, Rural Development, and Related Agencies Appropriations for 1982: Hearings Before a Subcommitee of the Committee on Appropriations, House of Representatives, Ninety-sixth Congress, First Session, Parts 5-6U.S. Government Printing Office, 1981 - United States |
From inside the book
Results 1-5 of 100
Page 57
... groups . Sixty - one ( 61 ) animals for each group are referenced in the records for this study . The original pro ... group . In any terato- logy study , more animals should always be bred than are needed for the experiment to account ...
... groups . Sixty - one ( 61 ) animals for each group are referenced in the records for this study . The original pro ... group . In any terato- logy study , more animals should always be bred than are needed for the experiment to account ...
Page 101
... Group C program of investigational drug sponsored for cancer therapy . Mr. WHITTEN . Are there no geographic limitations or limits of the available stocks of such drug ? Dr. NOVITCH . These sponsors are usually very responsive to re ...
... Group C program of investigational drug sponsored for cancer therapy . Mr. WHITTEN . Are there no geographic limitations or limits of the available stocks of such drug ? Dr. NOVITCH . These sponsors are usually very responsive to re ...
Page 105
... group may be established . 40 CFR Sec- tions 180.34 ( d ) , ( e ) and ( f ) set forth these schemes . To expand upon the existing toler- ance grouping schemes , EPA has been working during the past year with a special study group ...
... group may be established . 40 CFR Sec- tions 180.34 ( d ) , ( e ) and ( f ) set forth these schemes . To expand upon the existing toler- ance grouping schemes , EPA has been working during the past year with a special study group ...
Page 107
... Groups , each to examine the report on a segment of the overall problem as follows : Study Group I -- Definition of the limited use drug problem , its scope , its importance in terms of the public health . Attempts to define at what ...
... Groups , each to examine the report on a segment of the overall problem as follows : Study Group I -- Definition of the limited use drug problem , its scope , its importance in terms of the public health . Attempts to define at what ...
Page 108
... Group II -- Feasibility and specific mechanisms for provision of economic incentives to firms to develop patented or unpatented drugs of limited use or unpatented drugs with potential for widespread use . Study Group III -- Possibility ...
... Group II -- Feasibility and specific mechanisms for provision of economic incentives to firms to develop patented or unpatented drugs of limited use or unpatented drugs with potential for widespread use . Study Group III -- Possibility ...
Other editions - View all
Common terms and phrases
action activities additional aflatoxin agency agency's amended ampicillin analysis analyzed animal drugs appropriate approval approximately benzodiazepines blood budget Bureau carcinogen chemical cimetidine clinical Committee commodities compliance Conduct consumer contamination cosmetic costs determine digoxin dispensers distribution dose Drug Administration Drug Applications effects established Estimated evaluation facilities FDA's Federal Register feed Food and Drug Food Safety FSQS funds HOUSTON human implementation increase industry initial inspection investigations laboratory manufacturers meat and poultry medical devices ment methods methoxsalen million monitoring NOVITCH orphan drugs patient package inserts percent personnel pesticide petition pharmacists pharmacy phenytoin potential POULTRY PRODUCTS PPIs prescription drug problems procedures proposed radiation regulations regulatory reports request requirements response revised risk samples scientific September 12 Service SODIUM specific standards submitted testing thiazide tion toxic Toxicology USDA vaccines warfarin WHITTEN